Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA grants orphan drug status to Shire’s UC treatment SHP647

pharmaceutical-technologyDecember 04, 2017

Tag: FDA , Shire , orphan drugs

PharmaSources Customer Service